TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression

Kidney International

Volumn 56, Issue 5, 1999, Pages 1710-1720

  Hayashida, Tomoko ^a,b   Poncelet, Anne Christine ^a   Hubchak, Susan C ^a   Schnaper, H William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Cytokine; Mitogen activated protein kinase; Sclerosing process; Transforming growth factor ; Type I collagen

Indexed keywords

COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; DNA BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; MESANGIUM CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; DRUG EFFECT; MESANGIUM; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; COLLAGEN; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GLOMERULAR MESANGIUM; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032589970     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00733.x     Document Type: Article

References (48)

1. 1. KITAMURA M, SUTO TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669-679, 1997
2. 2. BRUIJN JA, ROOS A, DE GEUS B, DE HEER E: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123:34-47, 1994
3. 3. YOSHIOKA K, TAKEMURA T, MURAKAMI K, OKADA M, HINO S, MIYAMOTO H, MAKI S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
4. 4. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
5. 5. NIEMIR ZI, STEIN H, NORONHA IL, KRUGER C, ANDRASSY K, RITZ E, WALDHERR R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
6. 6. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
7. 7. SANDERSON N, FACTOR V, NAGY P, KOPP J, KONDAIAH P, WAKEFIELD L, ROBERTS AB, SPORN MB, THORGEIRSSON SS: Hepatic expression of mature transforming growth factor-β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995
8. 8. PONCELET AC, SCHNAPER HW: Regulation of human mesangial cell collagen expression by transforming growth factor-β1. Am J Physiol 275(3 Part 2):F458-F466, 1998
9. 9. SUZUKI S, EBIHARA I, TOMINO Y, KOIDE H: Transcriptional activation of matrix genes by transforming growth factor-β1 in mesangial cells. Exp Nephrol 1:229-237, 1993
10. 10. MCKAY NG, KHONG TF, HAITES NE, POWER DA: The effect of transforming growth factor-β1 on mesangial cell fibronectin synthesis: Increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing. Exp Mol Pathol 59:211-224, 1993
11. 11. TOMOOKA S, BORDER WA, MARSHALL BC, NOBLE NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992
12. 12. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 346:371-374, 1990
13. 13. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
14. 14. AKAGI Y, ISAKA Y, ARAI M, KANEKO T, TAKENAKA M, MORIYAMA T, KANEDA Y, ANDO A, ORITA Y, KAMADA T, UEDA N, IMAI E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
15. 15. MASSAGUE J: TGF-β signaling: Receptors, transducers, and Mad proteins. Cell 85:947-950, 1996
16. 16. JOSSO N, DI CLEMENTE N: Serine/threonine kinase receptors and ligands. Curr Opin Genet Dev 7:371-377, 1997
17. 17. KRETZSCHMAR M, MASSAGUE J: SMADs: Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 8:103-111, 1998
18. 18. HELDIN CH, MIYAZONO K, TEN DIJKE P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
19. 19. DENNLER S, ITOH S, VIVIEN D, TEN DIJKE P, HUET S, GAUTHIER JM: Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100, 1998
20. 20. JONK LJ, ITOH S, HELDIN CH, TEN DIJKE P, KRUIJER W: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145-21152, 1998
21. 21. LIU F, POUPONNOT C, MASSAGUE J: Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev 11:3157-3167, 1997
22. 22. CHEN X, WEISBERG E, FRIDMACHER V, WATANABE M, NACO G, WHITMAN M: Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89, 1997
23. 23. JANKNECHT R, WELLS NJ, HUNTER T: TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev 12:2114-2119, 1998
24. 24. FENG XH, ZHANG Y, WU RY, DERYNCK R: The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation. Genes Dev 12:2153-2163, 1998
25. 25. TOPPER JN, DICHIARA MR, BROWN JD, WILLIAMS AJ, FALB D, COLLINS T, GIMBRONE MA JR: CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc Natl Acad Sci USA 95:9506-9511, 1998
26. 26. PONCELET A, DE CAESTECKER M, SCHNAPER W: The TGF-β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56:1354-1365, 1999
27. 27. TREISMAN R: Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8:205-215, 1996
28. 28. SEGER R, KREBS EG: The MAPK signaling cascade. FASEB J 9:726-735, 1995
29. 29. HUWILER A, PFEILSCHIFTER J: Transforming growth factor-β2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 354:255-258, 1994
30. 30. MULDER KM, MORRIS SL: Activation of p21ras by transforming growth factor-β in epithelial cells. J Biol Chem 267:5029-5031, 1992
31. 31. YAMAGUCHI K, SHIRAKABE K, SHIBUYA H, IRIE K, OISHI I, UENO N, TANIGUCHI T, NISHIDA E, MATSUMOTO K: Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011, 1995
32. 32. YAN Z, WINAWER S, FRIEDMAN E: Two different signal transduction pathways can be activated by transforming growth factor-β1 in epithelial cells. J Biol Chem 269:13231-13237, 1994
33. 33. FREY RS, MULDER KM: Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor-β in the negative growth control of breast cancer cells. Cancer Res 57:628-633, 1997
34. 34. WRANA JL, ATTISANO L, CARCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F, MASSAGUE J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014, 1992
35. 35. CHEN TR: In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255-262, 1977
36. 36. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
37. 37. BOAST S, SU MW, RAMIREZ F, SANCHEZ M, AVVEDIMENTO EV: Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem 265:13351-13356, 1990
38. 38. ROBBINS DJ, ZHEN E, OWAKI H, VANDERBILT CA, EBERT D, GEPPERT TD, COBB MH: Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 268:5097-5106, 1993
39. 39. RANA A, GALLO K, GODOWSKI P, HIRAI S, OHNO S, ZON L, KYRIAKIS JM, AVRUCH J: The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J Biol Chem 271:19025-19028, 1996
40. 40. BATTEGAY EJ, RAINES EW, SEIFERT RA, BOWEN-POPE DF, ROSS R: TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524, 1990
41. 41. ARMENDARIZ-BORUNDA J, SIMKEVICH CP, ROY N, RAGHOW R, KANG AH, SEYER JM: Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J 304:817-824, 1994
42. 42. LI L, ARTLETT CM, JIMENEZ SA, HALL DJ, VARGA J: Positive regulation of human α1(I) collagen promoter activity by transcription factor Sp1. Gene 164:229-234, 1995
43. 43. NEHLS MC, GRAPILON ML, BRENNER DA: NF-1/Sp1 switch elements regulate collagen α1(I) gene expression. DNA Cell Biol 11:443-452, 1992
44. 44. CHEN SJYW, LEVENSON AS, MORI Y, TROJANOWSKA M, VARGA J: Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: Involvement of Smad3. J Invest Dermatol 112:49-57, 1998
45. 45. LABBE E, SILVESTRI C, HOODLESS PA, WRANA JL, ATTISANO L: Smad2 and Smad3 positively and negatively regulate TGF-β-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 2:109-120, 1998
46. 46. DE CAESTECKER MP, PARKS WT, FRANK CJ, CASTAGNINO P, BOTTARO DP, ROBERTS AB, LECHLEIDER RJ: Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12:1587-1592, 1998
47. 47. SHIBUYA H, YAMAGUCHI K, SHIRAKABE K, TONEGAWA A, GOTOH Y, UENO N, IRIE K, NISHIDA E, MATSUMOTO K: TAB1: An activator of the TAKI MAPKKK in TGF-β signal transduction. Science 272:1179-1182, 1996
48. 48. KRETZSCHMAR M, DOODY J, MASSAGUE J: Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad1. Nature 389:618-622, 1997